Today news
About the same in other media
US FDA approves J&J's blood cancer therapy
Reading now: 422
U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer.
The therapy, talquetamab-tgvs branded as Talvey, belongs to a class called bispecific antibodies designed to bring a cancer cell and an immune cell together so the body's immune system can kill the cancer. Talvey was approved as a weekly or biweekly subcutaneous, or under-the-skin, injection, the company said.
. Read more on economictimes.indiatimes.comAbout this in other media
US approves maternal vaccine to prevent RSV in infants economictimes.indiatimes.com /1 year ago
Dwindling optimism for Bitcoin ETF approval to blame as weekly crypto outflows hit $55M cointelegraph.com /1 year ago
Streaming smells blood in shark waters livemint.com /1 year ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
